Modalis Therapeutics Corporation

TSE:4883 Stock Report

Market Cap: JP¥2.7b

Modalis Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Haruhiko Morita

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.3yrs
CEO ownership17.6%
Management average tenureno data
Board average tenure5.8yrs

Recent management updates

Recent updates


CEO

Haruhiko Morita (54 yo)

8.3yrs

Tenure

Mr. Haruhiko Morita co-founded Modalis Therapeutics Corporation in January 2016 and serves as its President, Chief Executive Officer and Chairman of the board since January 2016. He served as President and...


Board Members

NamePositionTenureCompensationOwnership
Haruhiko Morita
Co-Founder8.3yrsno data17.62%
¥ 476.1m
Joseph S. McCracken
Outside Independent Director5.8yrsno datano data
Toshio Furuta
Outside Independent Director5.4yrsno data0.082%
¥ 2.2m
Teruhisa Tajima
Outside Independent Director5.8yrsno data0.32%
¥ 8.7m
Hideki Takeda
Outside Independent Director8.3yrsno data0.57%
¥ 15.3m
Miyuki Shimane
Outside Independent Director5.4yrsno data0.015%
¥ 394.9k

5.8yrs

Average Tenure

63yo

Average Age

Experienced Board: 4883's board of directors are considered experienced (5.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.